Back

PRIME Education, Inc. (PRIME®)

  • Triple Negative Breast Neoplasms

Emerging Therapies in Frontline mTNBC: Safety Profiles and Adverse Event Management

As new agents reshape treatment algorithms in metastatic triple-negative breast cancer (mTNBC), clinicians face growing challenges in applying evolving evidence and managing complex toxicities. Tune in to the second and final episode of this video podcast series to hear two oncology experts in mTNBC share practical insights on safety data and management of toxicities associated with emerging therapies in the frontline setting.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes On-demand / recorded video
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Nov 24, 2025
  • Last day to claim credit
    Nov 24, 2026 6 weeks left